Tisch MS Research Center of New York

Homepage: tischms.org

Alternate names: MS Research Center of New York, Multiple Sclerosis Research Center of New York, Tisch MSRCNY, Tisch Multiple Sclerosis Research Center of New York

ROR: 02q2rgf58

OpenAlex ID: I4405280285

Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells

2014 · Panagiotis Douvaras, Jing Wang, et al. · Stem Cell Reports · 312

PDF

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

2018 · Violaine K. Harris, James Stark, et al. · EBioMedicine · 180

PDF

Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis

2011 · Violaine K. Harris, Qi Jiang Yan, et al. · Journal of the Neurological Sciences · 131

Disease Biomarkers in Multiple Sclerosis: Potential for Use in Therapeutic Decision Making

2009 · Violaine K. Harris, Saud A. Sadiq · Molecular Diagnosis & Therapy · 107

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status

2014 · Violaine K. Harris, Saud A. Sadiq · Molecular Diagnosis & Therapy · 96

PDF

Biomarkers of multiple sclerosis: current findings

2017 · Violaine Harris, John Tuddenham, et al. · Degenerative Neurological and Neuromuscular Disease · 95

PDF

Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus

2008 · Tamara Vyshkina, Andrew Sylvester, et al. · Clinical Immunology · 90

Characterization of Autologous Mesenchymal Stem Cell-Derived Neural Progenitors as a Feasible Source of Stem Cells for Central Nervous System Applications in Multiple Sclerosis

2012 · Violaine K. Harris, Raihan Faroqui, et al. · Stem Cells Translational Medicine · 83

PDF

Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites

2019 · G. Luke Larkin, Alifiya Tahir, et al. · Ophthalmology and Therapy · 79

PDF

HDAC3 inhibition ameliorates spinal cord injury by immunomodulation

2017 · Tomoharu Kuboyama, Shalaka Wahane, et al. · Scientific Reports · 74

PDF

Clinical safety of intrathecal administration of mesenchymal stromal cell–derived neural progenitors in multiple sclerosis

2016 · Violaine K. Harris, Tamara Vyshkina, et al. · Cytotherapy · 73

Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects

2012 · Chiharu Kumagai, Bernadette Kalman, et al. · Journal of Neuroimmunology · 70

Mesenchymal Stem Cells Enhance the Engraftment and Myelinating Ability of Allogeneic Oligodendrocyte Progenitors in Dysmyelinated Mice

2011 · Massimiliano Cristofanilli, Violaine K. Harris, et al. · Stem Cells and Development · 64

Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis

2013 · Violaine K Harris, Nicola Donelan, et al. · Multiple Sclerosis Journal · 62

Inhibition of Hyaluronan Synthesis Protects against Central Nervous System (CNS) Autoimmunity and Increases CXCL12 Expression in the Inflamed CNS

2014 · Andre Michael Mueller, Bo Hyung Yoon, et al. · Journal of Biological Chemistry · 59

PDF

Intrathecal baclofen in multiple sclerosis: Too little, too late?

2011 · April Erwin, Mark Gudesblatt, et al. · Multiple Sclerosis Journal · 57

PDF

Specificity and Correlation With Disease Activity of Cerebrospinal Fluid Osteopontin Levels in Patients With Multiple Sclerosis

2008 · Soheli A. Chowdhury, Jerry Lin, et al. · Archives of Neurology · 51

JCV detection in multiple sclerosis patients treated with natalizumab

2010 · Saud A. Sadiq, Lauren M. Puccio, et al. · Journal of Neurology · 47

Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine‐induced blood brain barrier dysfunction via suppression of MLCK signaling pathway

2017 · Ying Liu, Marwan Alahiri, et al. · Immunity Inflammation and Disease · 44

PDF

Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial

2024 · Violaine K. Harris, James Stark, et al. · Stem Cell Research & Therapy · 43

Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study

2020 · Violaine K. Harris, James W. Stark, et al. · Neurology Neuroimmunology & Neuroinflammation · 42

PDF

A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines

2010 · Daryl Rhys Jones, William Alexander Taylor, et al. · PLoS ONE · 42

PDF

Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis

2012 · Andre Michael Müller, Esther Jun, et al. · Journal of Neuroimmunology · 36

Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity

2007 · S. A. Sadiq, C. A. Poopatana · Journal of Neurology · 33

The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid

2009 · André M. Mueller, Xiomara Pedré, et al. · Journal of Neuroimmunology · 32

Works count: 153

Citation count: 9,115